{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:37:29Z","timestamp":1780717049748,"version":"3.54.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.neuro.2009.04.014","type":"journal-article","created":{"date-parts":[[2009,5,23]],"date-time":"2009-05-23T04:29:29Z","timestamp":1243052969000},"page":"803-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Anti-cancer drugs interfere with intracellular calcium signaling"],"prefix":"10.1016","volume":"30","author":[{"given":"Ana-Maria","family":"Florea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"B\u00fcsselberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May (5)","key":"10.1016\/j.neuro.2009.04.014_bib1","first-page":"625","article-title":"Platinum compounds in cancer therapy\u2014past, present, and future","volume":"28","author":"Akaza","year":"2001","journal-title":"Gan To Kagaku Ryoho"},{"issue":"Suppl. 2","key":"10.1016\/j.neuro.2009.04.014_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.6-suppl_2-1","article-title":"Introduction: the history of arsenic trioxide in cancer therapy","volume":"6","author":"Antman","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.neuro.2009.04.014_bib3","first-page":"233","article-title":"Arsenic and old myths","volume":"77","author":"Aronson","year":"1994","journal-title":"R I Med"},{"issue":"7","key":"10.1016\/j.neuro.2009.04.014_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1155","article-title":"Calcium signalling: dynamics, homeostasis and remodelling","volume":"4","author":"Berridge","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"December (6)","key":"10.1016\/j.neuro.2009.04.014_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/138920106779116829","article-title":"Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug","volume":"7","author":"Bonati","year":"2006","journal-title":"Curr Pharm Biotechnol"},{"issue":"November\u2013December (6)","key":"10.1016\/j.neuro.2009.04.014_bib6","first-page":"1663","article-title":"Cisplatin and platinum drugs at the molecular level","volume":"10","author":"Boulikas","year":"2003","journal-title":"Oncol Rep"},{"issue":"April (4)","key":"10.1016\/j.neuro.2009.04.014_bib7","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1152\/jn.1994.71.4.1491","article-title":"Mammalian voltage-activated calcium channel currents are blocked by Pb2+, Zn2+, and Al3+","volume":"71","author":"B\u00fcsselberg","year":"1994","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuro.2009.04.014_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF02088676","article-title":"Mercury (Hg2+) and zinc (Zn2+)\u20142 divalent cations with different actions on voltage-activated calcium-channel currents","volume":"6","author":"B\u00fcsselberg","year":"1994","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.neuro.2009.04.014_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0378-4274(95)03559-1","article-title":"Calcium channels as target sites of heavy metals","volume":"82\u201383","author":"B\u00fcsselberg","year":"1995","journal-title":"Toxicol Lett"},{"issue":"January (1)","key":"10.1016\/j.neuro.2009.04.014_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152007779314044","article-title":"Biochemical mechanisms of cisplatin cytotoxicity","volume":"7","author":"Cepeda","year":"2007","journal-title":"Anticancer Agents Med Chem"},{"issue":"May\u2013June (3a)","key":"10.1016\/j.neuro.2009.04.014_bib11","first-page":"1529","article-title":"Metals and metal compounds in cancer treatment","volume":"24","author":"Desoize","year":"2004","journal-title":"Anticancer Res"},{"issue":"April (1)","key":"10.1016\/j.neuro.2009.04.014_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-8428(02)00017-3","article-title":"Cancer and metals and metal compounds: part I\u2014carcinogenesis","volume":"42","author":"Desoize","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"June (3)","key":"10.1016\/j.neuro.2009.04.014_bib13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1040-8428(02)00039-2","article-title":"Cancer and metals and metal compounds: part II\u2014cancer treatment","volume":"42","author":"Desoize","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"June (3)","key":"10.1016\/j.neuro.2009.04.014_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1040-8428(01)00219-0","article-title":"Particular aspects of platinum compounds used at present in cancer treatment","volume":"42","author":"Desoize","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"December (1\u20132)","key":"10.1016\/j.neuro.2009.04.014_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5955(02)00634-2","article-title":"Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways","volume":"174","author":"Devarajan","year":"2002","journal-title":"Hear Res"},{"issue":"October (6)","key":"10.1016\/j.neuro.2009.04.014_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ctrv.2007.05.001","article-title":"Arsenical-based cancer drugs","volume":"33","author":"Dilda","year":"2007","journal-title":"Cancer Treat Rev"},{"issue":"August (8)","key":"10.1016\/j.neuro.2009.04.014_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2007.07.001","article-title":"From traditional Chinese medicine to rational cancer therapy","volume":"13","author":"Efferth","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.neuro.2009.04.014_bib18","series-title":"Toxicity of alkylated derivatives of arsenic, antimony and tin: cellular uptake, cytotoxicity, genotoxic effects, perturbation of Ca2+ homeostasis and cell death","author":"Florea","year":"2005"},{"key":"10.1016\/j.neuro.2009.04.014_bib19","unstructured":"Florea AM. Arsenic trioxide (As2O3) interacts with [Ca2+]i of human SY-5Y neuroblastoma and human embryonic kidney 293 (HEK) cells and induces cytotoxicity. Inaugural \u2013 Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften in der Medizin durch die Medizinische Fakult\u00e4t der Universit\u00e4t Duisburg-Essen, Germany; 2007."},{"key":"10.1016\/j.neuro.2009.04.014_bib20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/mawe.200500960","article-title":"Toxic effects of metals: use, benefits and toxic cellular effects","volume":"36","author":"Florea","year":"2005","journal-title":"Materialwiss u Werkstofft"},{"issue":"4","key":"10.1016\/j.neuro.2009.04.014_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10534-005-4451-x","article-title":"Occurrence, use and potential toxic effects of metals and metal compounds","volume":"19","author":"Florea","year":"2006","journal-title":"Biometals"},{"key":"10.1016\/j.neuro.2009.04.014_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxlet.2008.03.019","article-title":"Arsenic trioxide in environmentally and clinically relevant concentrations alters calcium homeostasis and induces cell type specific apoptosis in tumour and nontumor cells","volume":"179","author":"Florea","year":"2008","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.neuro.2009.04.014_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/mawe.200800371","article-title":"Metal compounds (arsenic trioxide and trimehtyltin) interact with calcium homeostasis and trigger cell death in \u201cin vitro\u201d systems","volume":"1\u20132","author":"Florea","year":"2009","journal-title":"Materialwissenschaft und Werkstofftechnik"},{"issue":"3","key":"10.1016\/j.neuro.2009.04.014_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ceca.2004.10.005","article-title":"Elevated Ca2+(i) transients induced by trimethyltin chloride in HeLa cells: types and levels of response","volume":"37","author":"Florea","year":"2005","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.neuro.2009.04.014_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2005.05.029","article-title":"Modulation of intracellular calcium homeostasis by trimethyltin chloride in human tumor cells: neuroblastoma SY5Y and cervix adenocarcinoma HeLa S3","volume":"216","author":"Florea","year":"2005","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.neuro.2009.04.014_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1289\/ehp.7634","article-title":"Intracellular calcium disturbances induced by arsenic and its methylated derivatives in relation to genomic damage and apoptosis induction","volume":"113","author":"Florea","year":"2005","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neuro.2009.04.014_bib27","first-page":"292","article-title":"Mechanisms of arsenic trioxide (As2O3) induced calcium signals and cellular death in two human SY-5Y Neuroblastoma and 293 embryonic kidney (HEK) cells","volume":"May 220","author":"Florea","year":"2007","journal-title":"TAAP"},{"issue":"February (3)","key":"10.1016\/j.neuro.2009.04.014_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/0929867033368484","article-title":"Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways","volume":"10","author":"Fuertesa","year":"2003","journal-title":"Curr Med Chem"},{"issue":"April (4)","key":"10.1016\/j.neuro.2009.04.014_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/mol.59.4.657","article-title":"Is cisplatin-induced cell death always produced by apoptosis?","volume":"59","author":"Gonzalez","year":"2001","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.neuro.2009.04.014_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cbic.200800471","article-title":"Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA","volume":"10","author":"Guggenheim","year":"2009","journal-title":"Chembiochem"},{"issue":"2","key":"10.1016\/j.neuro.2009.04.014_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neuro.2008.12.001","article-title":"Co-application of arsenic trioxide (As2O3) and cisplatin (CDDP) on human SY-5Y neuroblastoma cells has differential effects on the intracellular calcium concentration ([Ca2+]i) and cytotoxicity","volume":"30","author":"G\u00fcnes","year":"2009","journal-title":"Neurotoxicology"},{"issue":"June (6)","key":"10.1016\/j.neuro.2009.04.014_bib32","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.4.6.889","article-title":"Toxicity of platinum compounds","volume":"4","author":"Hartmann","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.neuro.2009.04.014_bib33","first-page":"4488","article-title":"Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines","volume":"57","author":"Henkels","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.neuro.2009.04.014_bib34","first-page":"3077","article-title":"Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines","volume":"59","author":"Henkels","year":"1999","journal-title":"Cancer Res"},{"issue":"December (6)","key":"10.1016\/j.neuro.2009.04.014_bib35","doi-asserted-by":"crossref","first-page":"F1140","DOI":"10.1152\/ajprenal.00262.2004","article-title":"Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity","volume":"287","author":"Jiang","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.neuro.2009.04.014_bib36","first-page":"850","article-title":"Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines","volume":"57","author":"Johnson","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.neuro.2009.04.014_bib37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1254\/jphs.FP0050661","article-title":"Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury","volume":"100","author":"Kawai","year":"2006","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.neuro.2009.04.014_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/taap.2001.9157","article-title":"Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites","volume":"172","author":"Kitchin","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuro.2009.04.014_bib39","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1158\/0008-5472.CAN-05-0424","article-title":"Mitochondrial damage mediates genotoxicity of arsenic in mammalian cells","volume":"65","author":"Liu","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.neuro.2009.04.014_bib40","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1745-7254.2006.00345.x","article-title":"Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid","volume":"27","author":"Li","year":"2006","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.neuro.2009.04.014_bib41","first-page":"17","article-title":"Mechanism of opening of mitochondrial permeability transition pore induced by arsenic trioxide","volume":"25","author":"Ma","year":"2006","journal-title":"Ai Zheng"},{"issue":"5","key":"10.1016\/j.neuro.2009.04.014_bib42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0166-2236(00)01548-4","article-title":"Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders","volume":"23","author":"Mattson","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuro.2009.04.014_bib43","series-title":"Arsenic in drinking water","author":"NRC","year":"1999"},{"issue":"October (5)","key":"10.1016\/j.neuro.2009.04.014_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10147-007-0694-6","article-title":"PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia","volume":"12","author":"Ohnishi","year":"2007","journal-title":"Int J Clin Oncol"},{"issue":"7","key":"10.1016\/j.neuro.2009.04.014_bib45","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrm1150","article-title":"Regulation of cell death: the calcium-apoptosis link","volume":"4","author":"Orrenius","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.neuro.2009.04.014_bib46","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/j.1471-4159.2008.05297.x","article-title":"Dysregulation of intracellular calcium homeostasis is responsible for neuronal death in an experimental model of selective hippocampal degeneration induced by trimethyltin","volume":"105","author":"Piacentini","year":"2008","journal-title":"J Neurochem"},{"issue":"April (4)","key":"10.1016\/j.neuro.2009.04.014_bib47","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1681\/ASN.V134858","article-title":"Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways","volume":"13","author":"Park","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.neuro.2009.04.014_bib48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0306-4522(96)00335-1","article-title":"Alterations in hippocampal expression of SNAP-25, GAP-43, stannin and glial fibrillary acidic protein following mechanical and trimethyltin-induced injury in the rat","volume":"76","author":"Patanow","year":"1997","journal-title":"Neuroscience"},{"issue":"January\u2013February (1)","key":"10.1016\/j.neuro.2009.04.014_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/019262330002800107","article-title":"Mechanisms of injury in the central nervous system","volume":"28","author":"Philbert","year":"2000","journal-title":"Toxicol Pathol"},{"issue":"4","key":"10.1016\/j.neuro.2009.04.014_bib50","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jtemb.2008.08.002","article-title":"Metals and apoptosis: recent developments","volume":"22","author":"Rana","year":"2008","journal-title":"J Trace Elem Med Biol"},{"issue":"3 (Suppl. 2)","key":"10.1016\/j.neuro.2009.04.014_bib51","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1053\/j.seminhematol.2008.07.005","article-title":"Arsenic and old lace: novel approaches in elderly patients with acute myeloid leukemia","volume":"45","author":"Roboz","year":"2008","journal-title":"Semin Hematol"},{"issue":"1\u20132","key":"10.1016\/j.neuro.2009.04.014_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1383-5718(01)00289-3","article-title":"Antiproliferative and cytotoxic effect of a novel organotin compound on mammalian cells both in vitro and in vivo","volume":"513","author":"Syng-ai","year":"2002","journal-title":"Mutat Res"},{"issue":"4","key":"10.1016\/j.neuro.2009.04.014_bib53","first-page":"385","article-title":"Mitochondria, calcium and nitric oxide in the apoptotic pathway of esophageal carcinoma cells induced by As2O3","volume":"9","author":"Shen","year":"2002","journal-title":"Int J Mol Med"},{"issue":"March (3)","key":"10.1016\/j.neuro.2009.04.014_bib54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1248\/yakushi.127.451","article-title":"Recent studies on the trimethyltin actions in central nervous systems","volume":"127","author":"Shintani","year":"2007","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.neuro.2009.04.014_bib55","first-page":"6703","article-title":"Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells","volume":"48","author":"Sorenson","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.neuro.2009.04.014_bib56","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/sj.bjp.0707335","article-title":"IP3-receptor-antagonist 2-APB attenuates cisplatin induced Ca2+-influx in HeLa-S3 cells and prevents activation of calpain","volume":"151","author":"Splettstoesser","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"July (7)","key":"10.1016\/j.neuro.2009.04.014_bib57","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/000348949810700712","article-title":"Intracellular calcium changes and chemosensitivities of human epidermoid carcinoma cell lines after exposure to cisplatin","volume":"107","author":"Tachikawa","year":"1998","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"January (1)","key":"10.1016\/j.neuro.2009.04.014_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuro.2006.07.005","article-title":"Cisplatin modulates voltage gated channel currents of dorsal root ganglion neurons of rats","volume":"28","author":"Tomaszewski","year":"2007","journal-title":"Neurotoxicology"},{"issue":"November (6)","key":"10.1016\/j.neuro.2009.04.014_bib59","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neuro.2008.02.003","article-title":"SnCl2 reduces voltage-activated calcium channel currents of dorsal root ganglion neurons of rats","volume":"29","author":"Tomaszewski","year":"2008","journal-title":"Neurotoxicology"},{"issue":"3 (Suppl. 2)","key":"10.1016\/j.neuro.2009.04.014_bib60","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/j.seminhematol.2008.07.008","article-title":"The expanding role of arsenic in acute promyelocytic leukemia","volume":"45","author":"Tallman","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1016\/j.neuro.2009.04.014_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/bse0340191","volume":"34","author":"Trimmer","year":"1999","journal-title":"Cisplatin Essays Biochem"},{"issue":"3","key":"10.1016\/j.neuro.2009.04.014_bib62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.taap.2008.09.016","article-title":"Gene expression profiling analysis reveals arsenic-induced cell cycle arrest and apoptosis in p53-proficient and p53-deficient cells through differential gene pathways","volume":"233","author":"Yu","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"10.1016\/j.neuro.2009.04.014_bib63","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"issue":"July (7)","key":"10.1016\/j.neuro.2009.04.014_bib64","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1139\/w99-048","article-title":"Organotin compounds and their interactions with microorganisms","volume":"45","author":"White","year":"1999","journal-title":"Can J Microbiol"},{"issue":"2\u20133","key":"10.1016\/j.neuro.2009.04.014_bib65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0162-0134(03)00235-6","article-title":"New perspectives in arsenic-induced cell signal transduction","volume":"96","author":"Qian","year":"2003","journal-title":"J Inorg Biochem"},{"issue":"20","key":"10.1016\/j.neuro.2009.04.014_bib66","doi-asserted-by":"crossref","first-page":"10907","DOI":"10.1073\/pnas.94.20.10907","article-title":"Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression","volume":"94","author":"Zhao","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.neuro.2009.04.014_bib67","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1073\/pnas.0502825102","article-title":"Systems analysis of transcriptome and proteome in retinoic acid\/arsenic trioxide-induced cell differentiation\/apoptosis of promyelocytic leukaemia","volume":"102","author":"Zheng","year":"2005","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X09001120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X09001120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:15:55Z","timestamp":1758982555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X09001120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0161813X09001120"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2009.04.014","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-cancer drugs interfere with intracellular calcium signaling","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2009.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}